Keyphrases
Radioembolization
100%
Overall Survival
100%
Chemoembolization
100%
Locoregional Therapy
100%
Unresectable Hepatocellular Carcinoma
100%
Propensity Score Matching Study
100%
Progression-free Survival
66%
Adverse Events
66%
Propensity Score Matching
66%
Hepatocellular Carcinoma
33%
Comparative Analysis
33%
Tumor Response
33%
Doxorubicin
33%
Comparative Effectiveness
33%
Hepatocellular Cancer
33%
Disease Control Rate
33%
Resectable Disease
33%
Propensity Matching
33%
Treatment Selection Bias
33%
Comparative Toxicity
33%
Drug-eluting Beads
33%
Unresectable HCC
33%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Radioembolization
100%
Overall Survival
100%
Transcatheter Arterial Chemoembolization
100%
Adverse Event
66%
Progression Free Survival
66%
Propensity Score Matching
66%
Diseases
66%
Malignant Neoplasm
33%
Neoplasm
33%
Doxorubicin
33%
Selection Bias
33%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Overall Survival
100%
Progression Free Survival
66%
Adverse Event
66%
Diseases
66%
Neoplasm
33%
Malignant Neoplasm
33%
Doxorubicin
33%